This document discusses the concepts of loading and maintenance doses for drugs. It defines a loading dose as a larger initial dose used to quickly attain the steady-state drug concentration in plasma. The size of the loading dose depends on the maintenance dose, elimination rate constant, and dosing interval. It also discusses how to calculate loading doses based on either the maximum or minimum steady-state plasma concentration. After the loading dose, maintenance doses are given to maintain the steady-state concentration over the dosing interval. Factors like therapeutic index and drug half-life also impact maintaining concentrations within the therapeutic window.
3. INTRODUCTION
Most drugs for chronic condition are
prescribed in a dosage regimen is
based on the administration of a fixed
constant dose(D) at fixed regular
dosing intervals(T) for long period of
time.
The D & T recommended by the
manufacturer is based on the effective
therapeutic concentration of drug in
the plasma needed to treat the chronic
condition.
6/5/2022 3
4. The T is based on elimination rate
constant of the drug.
The steady-state concentration of drug
in plasma during multiple dosing is
given by following equation:
6/5/2022 4
5. The concentration of drug in plasma at
steady-state depends on the following
3 factors:
a) C0, concentration of drug in plasma.
b) Ke, elimination rate constant.
c) T, the dosing interval.
6/5/2022 5
6. DEFINITION & CONCEPT
Loading dose: A dose of medication,
often larger than subsequent doses,
administered for the purpose of
establishing a therapeutic level of the
medication.
Primary purpose of using loading dose in
therapeutic treatment is to attain steady-
state concentration of the drug as quickly
as possible, usually right from the start of
the dosage regimen for the treatment.
6/5/2022 6
7. This approach may also reduce the
time of onset of drug action, i.e; the
time its takes to achieve the minimum
effective concentration.
The purpose of administering the
loading dose is to reduce the time
needed for the drug to accumulate to
the steady-state level in the plasma.
The size of loading dose will depend
on the T of the maintenance dose.
6/5/2022 7
8. INTRAVENOUS
ADMINISTRATION
A drug when administered
intravenously as a single rapid bolus
dose, confers the characteristics of
one-compartment model on the body.
The main purpose of loading dose(D*)
is to provide a steady-state
concentration in plasma during
multiple dosing.
6/5/2022 8
9. Loading dose based on Cmax
ss
The max concentration of drug in the
plasma at steady-state, Cmax ss is given
by equation
C0 is plasma concentration
immediately after administration of a
single dose.
e-p is persistence factor where P=(Ke)
(T) 6/5/2022 9
10. If the drug follows linear
pharmacokinetics then C0 obtained
after the administration of single i.v
rapid bolus dose is directly
proportional to size of dose
D(maintenance dose).
The max concentration at steady-state
is
6/5/2022 10
11. Concentration of drug in plasma
immediately after administration of the
first dose is given by
Vd= apparent volume of distribution
therefore
6/5/2022 11
12. The max conc after the first dose is
Since Cmax 1 = Cmaxss, the conc *C0 of
drug in plasma immediately after (D*) is
given by
*C0 = Cmaxss
Substuting *C0 and Cmaxss gives
6/5/2022 12
13. The size of loading dose depends on
the following factors-
a) Maintenance dose ,D
b) Elimination rate constant , Ke
c) Dosing interval ,T.
6/5/2022 13
14. Loading dose based on Cmin ss
The minimum concentration of drug in
plasma at steady-state is given by
equation
If drug follows linear p’kinetics then C0
is directly proportional to size of D
The min concentration of drug in
plasma at steady-state is
6/5/2022 14
15. When a single bolus dose of the drug
is administered intravenously
Therefore
6/5/2022 15
16. The min conc of drug in plasma after
administration of first dose
For D* Cmin 1 = (*C0 ) (e-p ),which
should be equal to Cmin ss
Combining eq
6/5/2022 16
18. Factors affecting size of dose
If all doses and all T are kept
constant, then the size of D depends
on size of D*, T & Ke
Effect of dosing interval:
If the size of D is kept constant &
biological halflife of the drug dose not
change during the course of therapy,
the size of D* depends entirely upon
the T of a given drug.
6/5/2022 18
19. EXTRAVASCULAR
ADMINISTRATION
For the determination of D* during e.v,
administration, the simplest case is a
drug which, when administered,
confers upon the body the
characteristics of one-compartment
model, & does not exhibit lag-time.
The size of D* needed to attain
steady-sate conc of drug in plasma
depends on:
6/5/2022 19
20. a. Maximum concentration of drug in
plasma at steady state. OR
b. Minimum concentration of drug in
plasma at steady state.
LOADING DOSE BASED ON Cmaxss
The maximum concn of drug in
plasma at steady-state is given by
6/5/2022 20
21. Where B is the back extrapolated y-
intercept of the elimination phase after
administration of a single dose.
R=(Ke) (tmax)
6/5/2022 21
22. Loading dose based on Cmin ss
The minimum conc of drug in plasma
following e.v adminstration of n dose
If the drug follows linear
pharmacokinetics then B
F=fraction of dose absorbed
G= (Ka)( T)
6/5/2022 22
23. By setting n=1 in above eq in Cmin1
Canceling common terms
When n becomes large, the two
exponential terms e-np e-nG approach 0
6/5/2022 23
24. Since the y-intercept,Cmin1 is directly
proportional to D
If D is administered at the first dose
6/5/2022 24
25. When Cmin1=Cminss
Substituting the values
Bringing RHS of eq to common
denominator
Upon simplification
6/5/2022 25
26. Dividing both side by (e-p – e-G)
Cancelling common term
6/5/2022 26
27. Maintenance Dose
After the loading dose is given the
another dose is given to maintain the
steady- state drug conc. / plateau.
Such dose is known as maintenance
dose.
i.e. maintain the response of drug by
replacing drug lost during dosing
interval
6/5/2022 27
28. Maintenance dose = loading dose . ( 1- e kז)
Loading dose =
The ratio of loading dose to maintenance
dose (X0l/X0) is called as dose ratio
When ז = t1/2 the dose ratio =2.0
When ז > t1/2 the dose ratio < 2.0
when ז < t1/2 the dose ratio >2.0
6/5/2022 28
30. Maintenance of drug within the
therapeutic range
The ease or difficulty in maintaining drug
concentration within the therapeutic
window depends on-
The Therapeutic index of drug
The Half- life of drug
Convenience of dosing
6/5/2022 30
31. REFERENCE
Madan PL;Biopharmaceutics and
pharmacokinetics. Jaypee.2010(1);365-80.
Brahmankar DM, Sunil Jaiswal B;
Biopharmaceutics and Pharmacokinetics-
A Treatise. Vallabh publication. 2014(3);
374-76.
C V S Subrahmanyam. Textbook of
Biopharmaceutics & pharmacokinetics.1st
edition 2010;456-61.
6/5/2022 31